Yuichi Tambo

P-glycoprotein Mediates Ceritinib Resistance in Anaplastic Lymphoma Kinase-rearranged Non-small Cell Lung Cancer

Ryohei Katayama, Takuya Sakashita, Noriko Yanagitani et al. · EBioMedicine · 2015 · 139 citations · Full text

EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer

Rie Sakakibara, Kentaro Inamura, Yuichi Tambo et al. · Clinical Lung Cancer · 2016 · 127 citations

Medicine, Promising Method, Tumor Pd-l1 Expression +9

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, <i>EGFR</i> –Mutant, Metastatic Nonsquamous Non–Small Cell Lung Cancer

James Chih‐Hsin Yang, Dae Ho Lee, Jong‐Seok Lee et al. · Journal of Clinical Oncology · 2024 · 123 citations · Full text

Transformation to small-cell lung cancer following treatment with EGFR tyrosine kinase inhibitors in a patient with lung adenocarcinoma

Satoshi Watanabe, Takashi Sone, Tomoharu Matsui et al. · Lung Cancer · 2013 · 87 citations

Medicine, Lung Adenocarcinoma, Pathology +7

Sorafenib treatment for patients with RET fusion-positive non-small cell lung cancer

Atsushi Horiike, Kengo Takeuchi, Takeshi Uenami et al. · Lung Cancer · 2015 · 52 citations

Medicine, Sorafenib Treatment, Pathology +5